HL7 Terminology (THO)
3.0.0 - Publication

This page is part of the HL7 Terminology (v3.0.0: Release) based on FHIR R4. The current version which supercedes this version is 5.2.0. For a full list of available versions, see the Directory of published versions

CodeSystem: controlledSubstanceSchedule

Summary

Defining URL:http://terminology.hl7.org/CodeSystem/v2-0477
Version:2.1.0
Name:ControlledSubstanceSchedule
Status:Active as of 12/1/19
Definition:

Code system of concepts specifying the class of the drug or other substance if its usage is controlled by legislation. In the USA, such legislation includes the federal Controlled Substance Act (CSA) or a State Uniform Controlled Substance Act. Other countries should create their own versions of this table. Used in HL7 Version 2.x messaging in the RXE segment. The name of the table is taken from the Pharmacy Law Digest July 1988.

Publisher:HL7, Inc
Committee:Orders and Observations
Copyright:

Copyright HL7. Licensed under creative commons public domain

Content:Complete: All the concepts defined by the code system are included in the code system resource
OID:2.16.840.1.113883.18.304 (for OID based terminology systems)
Value Set:http://terminology.hl7.org/ValueSet/v2-0477 ( is the value set for all codes in this code system)
Source Resource:XML / JSON / Turtle

This Code system is referenced in the content logical definition of the following value sets:

Properties

CodeURLDescriptionType
statushttp://terminology.hl7.org/CodeSystem/utg-concept-properties#statusStatus of the conceptcode
deprecatedhttp://terminology.hl7.org/CodeSystem/utg-concept-properties#v2-table-deprecatedVersion of HL7 in which the code was deprecatedcode
v2-concCommenthttp://terminology.hl7.org/CodeSystem/utg-concept-properties#v2-concCommentV2 Concept Commentstring
v2-concCommentAsPubhttp://terminology.hl7.org/CodeSystem/utg-concept-properties#v2-concCommentAsPubV2 Concept Comment As Publishedstring

This code system http://terminology.hl7.org/CodeSystem/v2-0477 defines the following codes:

CodeDisplayDefinitionV2 Concept CommentV2 Concept Comment As Published
I Schedule ISchedule IIncludes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision.Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision.
II Schedule IISchedule IIIncludes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability.Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability.
III Schedule IIISchedule IIIIncludes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States.Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States.
IV Schedule IVSchedule IVIncludes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States.Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States.
V Schedule VSchedule VIncludes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States.Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States.
VI Schedule VISchedule VIState definedState defined

History

DateActionCustodianAuthorComment
2020-05-06reviseVocabulary WGTed KleinMigrated to the UTG maintenance environment and publishing tooling.